Menu
No results found.
AMS
Advanced Medical Solutions Group plc – LSE
Weekly Share Price & Valuation Overview
Market Overview
Open
204.0000
Close
201.5000
High
206.5000
Low
201.0000
Trend
0.39479
Advanced Medical Solutions Group plc
United Kingdom
• LSE - London Stock Exchange
• AMS
• Currency: GBp
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Key strengths
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Revenue growth ≥10% indicates solid top-line momentum.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
Potential weaknesses
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- GBp 444.06M
- Enterprise Value Operating value: market cap + total debt − cash.
- GBp 501.60M
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- GBp 177.52M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- GBp 92.62M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- GBp 22.70M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- GBp 0.83
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 0.03
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 1.29%
- Shares Outstanding
- 216.09M
- Float Shares
- 177.12M
- Implied Shares Outstanding
- 220.38M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
6.64%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
12.79%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
52.17%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
4.00%
- ROA Return on assets: net income ÷ total assets.
-
2.07%
- ROE Return on equity: net income ÷ shareholder equity.
-
2.94%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
73.50%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-58.20%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-58.10%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.55
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.36
- Total Cash Cash and equivalents.
- GBp 17.04M
- Total Debt Short + long-term interest-bearing debt.
- GBp 86.56M
- Net Debt Total debt − cash (negative = net cash).
- GBp 69.53M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 3.81
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- GBp 19.49M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- GBp -16.24M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
10.98%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-9.15%
- Cash Conversion (OpCF/EBITDA)
- 0.86
Sharemaestro House View
Confidence: 1
Sharemaestro internal conviction (0–3, higher is better).
Risk: 2
Sharemaestro internal risk profile (0–3, higher is safer).
Operational: 1
Operational quality/consistency (0–3, higher is better).
Composite Score: 2
Overall internal composite (0–3, higher is better).
Suggested Allocation: 3.33%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
82.0%
Insiders
Shares held by company insiders (officers, directors).
5.1%
Institutions
Shares held by institutions (funds, pensions).
70.6%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
2.0%
Net Debt
Total debt − cash (negative = net cash).
GBp 69.53M
39.2% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
47
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 03:52
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.